Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Transplant nephrology
How do you approach kidney transplant evaluation and management in an ESKD patient with a history of anti-GBM disease and currently detectable anti-GBM antibodies?
Related Questions
Would you rely on virtual crossmatch alone to proceed with a kidney transplant?
How do you distinguish TMA caused by CNI toxicity versus antibody mediated rejection in a kidney transplant patient?
How do you approach chronic T cell mediated rejection when patient is intolerant to steroids?
Do you recommend a metabolic evaluation in a kidney transplant patient with no prior history of nephrolithiasis who is found to have donor derived kidney stones?
How do you approach chronic active AMR concurrent with changes of CNI toxicity?
How would you approach the decision to biopsy a kidney transplant recipient who previously experienced a Page kidney following a kidney biopsy?
Would you refer a patient for kidney only or kidney and liver transplantation if they develop advanced chronic kidney disease secondary to primary hyperoxaluria type 2?
How do you approach the decision to perform preimplantation biopsies in brain-dead kidney donors?
Do you have specific waiting periods before a patient can be listed for a kidney transplant if they have a past history of malignancy?
Under what circumstances would you consider LDL apheresis in a kidney transplant patient with FSGS recurrence within three months of transplantation?
